Skip to main content
Clinical Trials/EUCTR2020-001769-35-FI
EUCTR2020-001769-35-FI
Active, not recruiting
Phase 1

Preventing urinary tract infections in infants and young children with probiotic E. coli Nissle: FinNiss- trial

Oulu University Hopsital0 sites530 target enrollmentMay 20, 2020

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
rinary tract infection
Sponsor
Oulu University Hopsital
Enrollment
530
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 20, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Oulu University Hopsital

Eligibility Criteria

Inclusion Criteria

  • Children aged less than two years treated due to urinary tract infection
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 530
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Age more than 2 years
  • Gestational age less than 35 weeks
  • Live threatening infection
  • Congenital intestinal or urinary tract anomaly requiring surgical treatment
  • Ongoing antimicrobial prophylaxis
  • Hospital originated infection

Outcomes

Primary Outcomes

Not specified

Similar Trials